Carpal tunnel syndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Carpal tunnel syndrome is primarily caused by compression of the median nerve within the carpal tunnel, a narrow passageway in the wrist. This compression often results from inflammation or swelling of the surrounding tendons (tenosynovitis), leading to increased pressure on the nerve.

• Secondary mechanism: Repetitive wrist movements or sustained wrist flexion/extension can exacerbate this condition by further narrowing the carpal tunnel space, contributing to nerve compression and subsequent ischemia. This results in impaired nerve conduction.

• Key complication: Prolonged compression of the median nerve can lead to sensory disturbances, such as pain, tingling, and numbness in the thumb, index, and middle fingers, and eventually motor dysfunction, including weakness or atrophy of the thenar muscles, impairing hand function.

Patient Profile

Demographics:

45-year-old female, office administrator

History:

• Key past medical history: Hypertension, type 2 diabetes

• Current medications: Lisinopril, Metformin, Ibuprofen (as needed)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in the right hand

• Key symptoms: Pain and weakness in the right hand, especially at night; difficulty gripping objects; occasional swelling in the fingers

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 160 mg/dL (fasting)

Section 1

Over the past week, the patient has experienced a noticeable change in her symptoms, indicating a potential complication in her carpal tunnel syndrome. She reports an increase in the intensity and frequency of the numbness and tingling in her right hand, now extending to the forearm. The pain, which was previously intermittent, has become more constant and is particularly bothersome during her work hours, affecting her ability to type and complete administrative tasks. Upon physical examination, there is observable atrophy of the thenar eminence, suggesting involvement of the motor fibers of the median nerve. Additionally, the Phalen's and Tinel's tests are both positive, indicating significant irritation of the median nerve.

Her blood glucose levels have also been persistently elevated, with a recent reading of 185 mg/dL, suggesting suboptimal control of her type 2 diabetes. This may contribute to the worsening of her symptoms, as poorly managed diabetes can lead to neuropathy and exacerbate nerve compression issues. Given her history of hypertension and diabetes, the inflammation and swelling in the carpal tunnel could be further aggravated, leading to more severe nerve compression.

The clinical team decides to perform an electromyography (EMG) and nerve conduction study to assess the extent of nerve damage and to confirm the diagnosis of carpal tunnel syndrome. The results show delayed nerve conduction velocity in the median nerve at the wrist, confirming significant compression. These findings highlight the need for a comprehensive management plan that not only addresses the mechanical compression but also optimizes her diabetes and hypertension control to prevent further complications. The patient is counseled on the importance of glycemic control, and a referral to a hand specialist is made to discuss potential surgical intervention as conservative measures have not yielded significant improvement.

Section 2

As the clinical team continues to monitor the patient's status, her condition exhibits a change that suggests new complications. Over the past few days, she has developed swelling and erythema in her right hand and wrist, alongside a mild fever of 100.4°F, raising concerns about a possible secondary infection or inflammatory process. The patient reports increased stiffness and a noticeable decrease in her range of motion, particularly in the morning, which gradually improves throughout the day but remains significantly impaired compared to her baseline. Her grip strength has also diminished, complicating her ability to perform daily activities both at home and work.

Laboratory tests are promptly conducted to investigate these new symptoms. Her complete blood count reveals a slight leukocytosis with a white blood cell count of 12,500/µL, indicative of a potential inflammatory or infectious process. C-reactive protein (CRP) levels are elevated at 15 mg/L, further supporting the presence of systemic inflammation. These findings, combined with her clinical presentation, necessitate a differential diagnosis that includes infectious tenosynovitis, exacerbation of her carpal tunnel syndrome due to inflammatory arthritis, or cellulitis secondary to unnoticed skin breach.

In response to these developments, the clinical team initiates a treatment plan that includes a course of broad-spectrum antibiotics to address the potential infection, pending further culture results. The patient is advised to rest the affected hand, apply ice intermittently, and continue using a wrist splint to minimize movement and prevent further irritation of the median nerve. Additionally, her diabetes management is intensified with adjustments to her medication regimen and dietary counseling to achieve better glycemic control, as this will be crucial in mitigating inflammation and improving overall outcomes. This multifaceted approach aims to address both the immediate complications and the underlying factors contributing to her carpal tunnel syndrome, setting the stage for the next steps in her care journey.

Section 3

The patient's response to the initial interventions reveals a mixed clinical picture, prompting the team to reassess and refine the treatment plan. Over the next 48 hours, her fever subsides slightly to 99.8°F, and she reports a mild reduction in swelling and erythema in her right hand and wrist. However, the stiffness and diminished range of motion persist, with only marginal improvement in her grip strength. This suggests that while the antibiotics may be addressing a potential infection, there is an underlying inflammatory component that remains unresolved.

Follow-up laboratory tests show her white blood cell count has decreased slightly to 11,800/µL, but CRP levels remain elevated at 14 mg/L, indicating sustained systemic inflammation. Additionally, blood glucose monitoring reveals episodes of hyperglycemia, with fasting blood sugar levels fluctuating between 150-180 mg/dL, despite adjustments in her diabetes management. These findings point to the need for a more comprehensive approach to managing her inflammatory symptoms and optimizing glycemic control, which may include consultation with a rheumatologist or endocrinologist to explore potential autoimmune or metabolic contributors to her condition.

Given these developments, the clinical team considers introducing a nonsteroidal anti-inflammatory drug (NSAID) to further reduce inflammation and improve her range of motion. Alongside pharmacological interventions, occupational therapy is recommended to help the patient regain function and adapt her daily activities to accommodate her current limitations. This multifaceted strategy aims not only to address the immediate symptoms but also to prevent further complications and enhance her quality of life, guiding the next steps in her recovery journey.

Section 4

Over the next 24 hours, the patient begins a regimen of NSAIDs, alongside intensive occupational therapy sessions designed to improve her hand function and address the persistent stiffness. During this period, the clinical team closely monitors her response to these interventions, noting any changes in her condition. Initial assessments reveal that while the patient experiences a slight reduction in pain, there remains a significant stiffness in the wrist, and her grip strength shows no substantial improvement. This prompts concern that the inflammation may not be fully addressed by NSAIDs alone.

In the following days, new diagnostic results emerge, providing further insight into the underlying issues. An MRI of the wrist is conducted to assess for structural abnormalities or persistent inflammatory changes. The imaging reveals tenosynovitis affecting the flexor tendons, contributing to her ongoing symptoms. This reinforces the notion that while infection appears to be controlled, inflammation remains a significant barrier to her recovery. Additionally, despite ongoing adjustments, her blood glucose levels continue to fluctuate, suggesting a need for further refinement in her diabetes management strategy.

This evolving clinical picture necessitates a strategic reassessment by the healthcare team. They consider the potential benefits of integrating more targeted therapies, such as corticosteroid injections, to more effectively address the tenosynovitis. Simultaneously, a consultation with an endocrinologist is prioritized to optimize her glycemic control, potentially exploring the use of newer diabetic medications. These steps are aimed at not only alleviating her current symptoms but also preventing the progression of complications, thereby enhancing her overall quality of life and paving the way for a more comprehensive and personalized treatment plan.

Section 5

Over the next 48 hours, the healthcare team initiates corticosteroid injections to directly target the tenosynovitis revealed by the MRI. This decision is made in light of the patient's inadequate response to NSAIDs and ongoing stiffness and pain in her wrist. Following the first injection, the patient reports a noticeable decrease in pain intensity and a slight improvement in wrist flexibility. However, her grip strength remains weak, indicating that while the inflammation is being addressed, muscle function recovery may take longer.

Simultaneously, the consultation with the endocrinologist leads to adjustments in her diabetes management. The endocrinologist recommends transitioning the patient to a newer class of diabetes medication, an SGLT2 inhibitor, to stabilize her blood glucose levels more effectively. Over the next few days, her glucose readings show a gradual improvement, with levels trending closer to the target range. This adjustment not only aids in controlling her diabetes but also potentially reduces systemic inflammation, which may contribute to her musculoskeletal symptoms.

Despite these positive developments, the patient begins to experience mild paresthesia in her fingers, raising concerns about possible nerve involvement. A follow-up nerve conduction study is ordered to evaluate the extent of nerve compression and guide further management. As the team awaits these results, they emphasize the importance of continued occupational therapy and encourage the patient to perform recommended hand exercises regularly. This comprehensive approach aims to enhance her hand function while addressing both her endocrine and orthopedic concerns, setting the stage for ongoing recovery and monitoring for any emerging complications.